BACKGROUND: CCR5 is a main co-receptor for HIV, but also homes lymphocytes to sites of inflammation. We hypothesized that inhibition of CCR5 signaling would reduce HIV-associated chronic immune activation. METHODS: To test this hypothesis, we administered an antagonistic anti-CCR5 monoclonal antibody (HGS101) to five uninfected rhesus macaques (RMs) and monitored lymphocyte dynamics in blood and tissue. RESULTS: CCR5 blockade resulted in decreased levels of CCR5+ T cells in blood and, at later timepoints, in lymph nodes. Additionally, the levels of CD25+ T cells increased in lymph nodes, but decreased in blood, bone marrow, and rectal mucosa. Finally, a profile of gene expression from HGS101-treated RMs revealed a subtle, but consistent, in vivo signature of CCR5 blockade that suggests a mild immune-modulatory effect. CONCLUSIONS: Treatment with anti-CCR5 antibody induces changes in the tissue distribution of CCR5+ and CD25+ T cells that may impact on the overall levels of immune activation during HIV and SIV infection.
BACKGROUND:CCR5 is a main co-receptor for HIV, but also homes lymphocytes to sites of inflammation. We hypothesized that inhibition of CCR5 signaling would reduce HIV-associated chronic immune activation. METHODS: To test this hypothesis, we administered an antagonistic anti-CCR5 monoclonal antibody (HGS101) to five uninfected rhesus macaques (RMs) and monitored lymphocyte dynamics in blood and tissue. RESULTS:CCR5 blockade resulted in decreased levels of CCR5+ T cells in blood and, at later timepoints, in lymph nodes. Additionally, the levels of CD25+ T cells increased in lymph nodes, but decreased in blood, bone marrow, and rectal mucosa. Finally, a profile of gene expression from HGS101-treated RMs revealed a subtle, but consistent, in vivo signature of CCR5 blockade that suggests a mild immune-modulatory effect. CONCLUSIONS: Treatment with anti-CCR5 antibody induces changes in the tissue distribution of CCR5+ and CD25+ T cells that may impact on the overall levels of immune activation during HIV and SIV infection.
Authors: Jeffrey M Jacobson; Melanie A Thompson; Jacob P Lalezari; Michael S Saag; Barry S Zingman; Paul D'Ambrosio; Nancy Stambler; Yakov Rotshteyn; Andre J Marozsan; Paul J Maddon; Stephen A Morris; William C Olson Journal: J Infect Dis Date: 2010-05-15 Impact factor: 5.226
Authors: David A Cooper; Jayvant Heera; James Goodrich; Margaret Tawadrous; Michael Saag; Edwin Dejesus; Nathan Clumeck; Sharon Walmsley; Naitee Ting; Eoin Coakley; Jacqueline D Reeves; Gustavo Reyes-Teran; Mike Westby; Elna Van Der Ryst; Prudence Ive; Lerato Mohapi; Horacio Mingrone; Andrzej Horban; Frances Hackman; John Sullivan; Howard Mayer Journal: J Infect Dis Date: 2010-03-15 Impact factor: 5.226
Authors: Michael A Weinreich; Kensuke Takada; Cara Skon; Steven L Reiner; Stephen C Jameson; Kristin A Hogquist Journal: Immunity Date: 2009-07-17 Impact factor: 31.745
Authors: Steven E Bosinger; Qingsheng Li; Shari N Gordon; Nichole R Klatt; Lijie Duan; Luoling Xu; Nicholas Francella; Abubaker Sidahmed; Anthony J Smith; Elizabeth M Cramer; Ming Zeng; David Masopust; John V Carlis; Longsi Ran; Thomas H Vanderford; Mirko Paiardini; R Benjamin Isett; Don A Baldwin; James G Else; Silvija I Staprans; Guido Silvestri; Ashley T Haase; David J Kelvin Journal: J Clin Invest Date: 2009-12 Impact factor: 14.808
Authors: Nichole R Klatt; Emi Shudo; Alex M Ortiz; Jessica C Engram; Mirko Paiardini; Benton Lawson; Michael D Miller; James Else; Ivona Pandrea; Jacob D Estes; Cristian Apetrei; Joern E Schmitz; Ruy M Ribeiro; Alan S Perelson; Guido Silvestri Journal: PLoS Pathog Date: 2010-01-29 Impact factor: 6.823
Authors: Jamal Suleiman; Barry S Zingman; Ricardo Sobhie Diaz; Jose Valdez Ramalho Madruga; Edwin DeJesus; Jihad Slim; Carmen Mak; Erin Lee; Michael C McCarthy; Lisa M Dunkle; Sharon Walmsley Journal: J Infect Dis Date: 2010-02-15 Impact factor: 5.226
Authors: Sudhir Pai Kasturi; Pamela A Kozlowski; Helder I Nakaya; Matheus C Burger; Pedro Russo; Mathew Pham; Yevgeniy Kovalenkov; Eduardo L V Silveira; Colin Havenar-Daughton; Samantha L Burton; Katie M Kilgore; Mathew J Johnson; Rafiq Nabi; Traci Legere; Zarpheen Jinnah Sher; Xuemin Chen; Rama R Amara; Eric Hunter; Steven E Bosinger; Paul Spearman; Shane Crotty; Francois Villinger; Cynthia A Derdeyn; Jens Wrammert; Bali Pulendran Journal: J Virol Date: 2017-01-31 Impact factor: 5.103
Authors: Thomas H Vanderford; Chloe Slichter; Kenneth A Rogers; Benton O Lawson; Rend Obaede; James Else; Francois Villinger; Steven E Bosinger; Guido Silvestri Journal: Blood Date: 2012-05-01 Impact factor: 22.113
Authors: Jacob Couturier; Alexander T Hutchison; Miguel A Medina; Cosmina Gingaras; Petri Urvil; Xiaoying Yu; Chi Nguyen; Parag Mahale; Lin Lin; Claudia A Kozinetz; Joern E Schmitz; Jason T Kimata; Tor C Savidge; Dorothy E Lewis Journal: Virology Date: 2014-07-04 Impact factor: 3.616
Authors: Jeffrey M Jacobson; Steven E Bosinger; Minhee Kang; Pablo Belaunzaran-Zamudio; Roy M Matining; Cara C Wilson; Charles Flexner; Brian Clagett; Jill Plants; Sarah Read; Lynette Purdue; Laurie Myers; Linda Boone; Pablo Tebas; Princy Kumar; David Clifford; Daniel Douek; Guido Silvestri; Alan L Landay; Michael M Lederman Journal: AIDS Res Hum Retroviruses Date: 2016-04-19 Impact factor: 2.205
Authors: Xiao L Chang; Helen L Wu; Gabriela M Webb; Meenakshi Tiwary; Colette Hughes; Jason S Reed; Joseph Hwang; Courtney Waytashek; Carla Boyle; Cleiton Pessoa; Andrew W Sylwester; David Morrow; Karina Belica; Miranda Fischer; Scott Kelly; Nader Pourhassan; Rachele M Bochart; Jeremy Smedley; Christopher P Recknor; Scott G Hansen; Jonah B Sacha Journal: Front Immunol Date: 2021-11-19 Impact factor: 8.786